Insys Therapeutics is in a long-tail liquidation and claims-administration phase, with the recent docket focused on maintaining the claims register and resolving individual claim entries rather than operating-company restructuring. In July 2026, the claims agent filed updated alphabetical and numerical registers for Insys and its affiliated debtors; the register records asserted, allowed, expunged, withdrawn, amended, and other disposition statuses across the case. July 2026 quarterly claims registerDkt. 2095